Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.
|Number of pages||2|
|Journal||Novel Approaches in Drug Designing & Development|
|Publication status||Published - 2 Jun 2017|